Seeking Alpha

CV Therapeutics Inc. (CVTX)

()

Comments on CVTX

  • Eton Park Loads Up on Options [View article]
    All of the positions in this article (taken via their 13F filing) are long positions. i.e. long calls, long puts, etc. What's... More »
    Comment by Market Folly
    Sep 3 15:07 pm |
    Rating: +2 0
  • Eton Park Loads Up on Options [View article]
    Yes, very good research on compiling hedge fund filings. I appreciate how you stated it is difficult to tell what their bias is with... More »
    Comment by C.S. Jefferson
    Sep 3 02:44 am |
    Rating: +2 0
  • Eton Park Loads Up on Options [View article]
    Keep up the good and very informative work
    Comment by knight
    Sep 2 09:33 am |
    Rating: +1 0
  • Manikay Partners Buy Healthcare, Dump Financials [View article]
    Either this post is months old or the writer is woefully uninformed. ROH was swallowed by Doe a few months ago. PCZ was swallowed by SU... More »
    Comment by skwestorange
    Aug 11 14:43 pm |
    Rating: 0 0
  • Health Care Trends Part 2: M&A, Generic Competition, CROs [View article]
    I just wanted to add some value-added info to this comment board as well. A solid up-and-coming pharmaceutical play is Access... More »
    Comment by svygear
    Jun 8 15:50 pm |
    Rating: 0 0
  • Health Care Trends Part 2: M&A, Generic Competition, CROs [View article]
    Retired Pharma - you may be an expert in medicine, but you don't know much about politics. Nobody believes that we can add 50 million... More »
    Comment by bbowen7
    Jun 7 15:38 pm |
    Rating: 0 0
  • Health Care Trends Part 2: M&A, Generic Competition, CROs [View article]
    The VA has automated, though not up-to-date as they do employ bureaucrats, for a decade. When the government socializes the system... More »
    Comment by Prudent Man CFA
    Jun 7 12:24 pm |
    Rating: +2 0
  • Health Care Trends Part 2: M&A, Generic Competition, CROs [View article]
    IT is already heavily employed in the docs office. I saw this in Maryland prior to retiring in 2007 and I see it now in Delaware where I... More »
    Comment by retiredpharma
    Jun 7 10:04 am |
    Rating: 0 0
  • Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly [View article]
    Last time I checked FDA did not cosider stock valuations in their BLA or PAI approval processes. Since your familiarity with regulatory... More »
    Comment by Seeking Accuracy
    May 1 12:56 pm |
    Rating: 0 0
  • Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly [View article]
    HGSI should be able to sell albuferon at a lower price per dosage than Pegasys because pegylation is an expensive process. Because it... More »
    Comment by Druglord
    Apr 11 14:55 pm |
    Rating: 0 0
  • Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly [View article]
    Most reasonable people would consider a 68 percent haircut in one day a failure. On Apr 02 09:45 AM Seeking Accuracy wrote: >... More »
    Comment by Mark Cifra
    Apr 2 10:37 am |
    Rating: 0 0
  • Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly [View article]
    WHY DID YOU LEAVE 'MRNA' OUT OF YOUR ARTCLE? AFTER ALL, IT IS A NEW COMPANY, NEW CEO, MADE TWO PARTNERING DEALS WITHIN 60 DAYS THIS... More »
    Comment by jimmy Turano
    Apr 2 10:14 am |
    Rating: +1 -4
  • Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly [View article]
    HGSI's phase 3 trial for albuferon did not fail. In fact, the defined endpoint of non-inferiority was successfully met. The SVR was... More »
    Comment by Seeking Accuracy
    Apr 2 09:45 am |
    Rating: +2 -1
  • Cramer's Lightning Round - So Sohu Me (3/26/09) [View article]
    Foster Wheeler ticker is FWLT not FCX. FCX is Freeport McMoran TaurusTrader http://www.taurustrader.wordpress.com
    Comment by TaurusTrader
    Mar 27 12:46 pm |
    Rating: +1 0
  • Cramer's Lightning Round - So Sohu Me (3/26/09) [View article]
    Do you think Cramer's still licking the wounds that Comedy Central dished out? LOL
    Comment by ksmithdc
    Mar 27 08:37 am |
    Rating: 0 0